692 related articles for article (PubMed ID: 34479163)
1. Aquatic concentration and risk assessment of pharmaceutically active compounds in the environment.
Dos Santos CR; Arcanjo GS; de Souza Santos LV; Koch K; Amaral MCS
Environ Pollut; 2021 Dec; 290():118049. PubMed ID: 34479163
[TBL] [Abstract][Full Text] [Related]
2. Investigation of pharmaceutically active compounds in an urban receiving water: Occurrence, fate and environmental risk assessment.
Liu J; Dan X; Lu G; Shen J; Wu D; Yan Z
Ecotoxicol Environ Saf; 2018 Jun; 154():214-220. PubMed ID: 29476970
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: removal and ecotoxicological impact of wastewater discharges and sludge disposal.
Martín J; Camacho-Muñoz D; Santos JL; Aparicio I; Alonso E
J Hazard Mater; 2012 Nov; 239-240():40-7. PubMed ID: 22608399
[TBL] [Abstract][Full Text] [Related]
4. Risk screening of pharmaceutical compounds in Romanian aquatic environment.
Gheorghe S; Petre J; Lucaciu I; Stoica C; Nita-Lazar M
Environ Monit Assess; 2016 Jun; 188(6):379. PubMed ID: 27234514
[TBL] [Abstract][Full Text] [Related]
5. Do pharmaceuticals reach and affect the aquatic ecosystems in Brazil? A critical review of current studies in a developing country.
Quadra GR; Oliveira de Souza H; Costa RD; Fernandez MA
Environ Sci Pollut Res Int; 2017 Jan; 24(2):1200-1218. PubMed ID: 27734317
[TBL] [Abstract][Full Text] [Related]
6. Occurrence, fate and ecotoxicological assessment of pharmaceutically active compounds in wastewater and sludge from wastewater treatment plants in Chongqing, the Three Gorges Reservoir Area.
Yan Q; Gao X; Chen YP; Peng XY; Zhang YX; Gan XM; Zi CF; Guo JS
Sci Total Environ; 2014 Feb; 470-471():618-30. PubMed ID: 24176710
[TBL] [Abstract][Full Text] [Related]
7. Occurrence and risk assessment of pharmaceuticals in surface waters of the Middle East and North Africa: A review.
Mheidli N; Malli A; Mansour F; Al-Hindi M
Sci Total Environ; 2022 Dec; 851(Pt 2):158302. PubMed ID: 36030863
[TBL] [Abstract][Full Text] [Related]
8. A review of the biotransformations of priority pharmaceuticals in biological wastewater treatment processes.
Nguyen PY; Carvalho G; Reis MAM; Oehmen A
Water Res; 2021 Jan; 188():116446. PubMed ID: 33038717
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutically active compounds in aqueous environment: recent developments in their fate, occurrence and elimination for efficient water purification.
Bangia S; Bangia R; Daverey A
Environ Monit Assess; 2023 Oct; 195(11):1344. PubMed ID: 37857877
[TBL] [Abstract][Full Text] [Related]
10. Occurrence, bioaccumulation and risk assessment of lipophilic pharmaceutically active compounds in the downstream rivers of sewage treatment plants.
Liu J; Lu G; Xie Z; Zhang Z; Li S; Yan Z
Sci Total Environ; 2015 Apr; 511():54-62. PubMed ID: 25531589
[TBL] [Abstract][Full Text] [Related]
11. Biodegradability, environmental risk assessment and ecological footprint in wastewater technologies for pharmaceutically active compounds removal.
Dos Santos CR; Lebron YAR; Moreira VR; Koch K; Amaral MCS
Bioresour Technol; 2022 Jan; 343():126150. PubMed ID: 34678454
[TBL] [Abstract][Full Text] [Related]
12. Status of pharmaceuticals in the Korle Lagoon and their toxicity to non-target organisms.
Asare EA
Ecotoxicology; 2022 Mar; 31(2):299-311. PubMed ID: 34981244
[TBL] [Abstract][Full Text] [Related]
13. Environmental risk assessment of diclofenac residues in surface waters and wastewater: a hidden global threat to aquatic ecosystem.
Hanif H; Waseem A; Kali S; Qureshi NA; Majid M; Iqbal M; Ur-Rehman T; Tahir M; Yousaf S; Iqbal MM; Khan IA; Zafar MI
Environ Monit Assess; 2020 Mar; 192(4):204. PubMed ID: 32124056
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutically active compounds in sludge stabilization treatments: anaerobic and aerobic digestion, wastewater stabilization ponds and composting.
Martín J; Santos JL; Aparicio I; Alonso E
Sci Total Environ; 2015 Jan; 503-504():97-104. PubMed ID: 24909712
[TBL] [Abstract][Full Text] [Related]
15. [Distribution and Environmental Risk of Pharmaceutically Active Compounds in the Traditionally Aqueous Phase of Effluent-receiving Rivers].
Wang S; Liu JC; Zheng CY; Zhang JC; Xu JC; Xu YY; Lu GH
Huan Jing Ke Xue; 2019 Apr; 40(4):1797-1802. PubMed ID: 31087921
[TBL] [Abstract][Full Text] [Related]
16. Hazard and health risk assessment of exposure to pharmaceutical active compounds via toxicological evaluation by zebrafish.
Ben Chabchoubi I; Lam SS; Pane SE; Ksibi M; Guerriero G; Hentati O
Environ Pollut; 2023 May; 324():120698. PubMed ID: 36435277
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and risk assessment of pharmaceutically active compounds in water supply systems in Brazil.
Santos AV; Couto CF; Lebron YAR; Moreira VR; Foureaux AFS; Reis EO; Santos LVS; de Andrade LH; Amaral MCS; Lange LC
Sci Total Environ; 2020 Dec; 746():141011. PubMed ID: 32763601
[TBL] [Abstract][Full Text] [Related]
18. Occurrence and indicators of pharmaceuticals in Chinese streams: A nationwide study.
Yao B; Yan S; Lian L; Yang X; Wan C; Dong H; Song W
Environ Pollut; 2018 May; 236():889-898. PubMed ID: 29042137
[TBL] [Abstract][Full Text] [Related]
19. Occurrence and ecological risks of pharmaceuticals in a Mediterranean river in Eastern Spain.
Fonseca E; Hernández F; Ibáñez M; Rico A; Pitarch E; Bijlsma L
Environ Int; 2020 Nov; 144():106004. PubMed ID: 32745782
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceuticals as emerging contaminants in the aquatic environment of Latin America: a review.
Valdez-Carrillo M; Abrell L; Ramírez-Hernández J; Reyes-López JA; Carreón-Diazconti C
Environ Sci Pollut Res Int; 2020 Dec; 27(36):44863-44891. PubMed ID: 32986197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
